<DOC>
	<DOCNO>NCT01922908</DOCNO>
	<brief_summary>The purpose study determine mesenchymal stem cell give IV feasible safe patient recent ischemic stroke decide maximum tolerated dose give 3-10 day ischemic stroke .</brief_summary>
	<brief_title>Mesenchymal Stromal Cells Ischemic Stroke</brief_title>
	<detailed_description>This randomize , double-blind , placebo control study . . Approximately 48 subject enrol trial , undergo real SHAM MSC IV infusion follow 1 year . There potentially 4 Cohorts dose escalation 3:1 randomization schedule Objectives : - The primary hypothesis ' intravenous administration allogeneic bone marrow derive mesenchymal stem cell feasible safe patient recent ischemic stroke determine maximum tolerate dose ( MTD ) IV MSCs administer sub-acutely 3-10 day follow ischemic stroke . - The secondary hypothesis allogeneic MSC transplantation improve functional outcome recent ischemic stroke . Safety clinical efficacy point evaluate Day 7 clinic visit , Day 30 , Day 60 , Day 90 , Day 180 . Primary outcome Primary endpoint study define safety harm MSCs</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>1. acute ischemic stroke 2. age 18 83 year 3. post stroke mRS &gt; 3 4 . NIHSS 725 5 . Deficits total NIHSS low 7 provide patient moderate aphasia visual loss ( 2 Best Language Visual loss NIHSS subcomponent ) *Criteria mRS use category subject 6 . Last see normal st within 39 day prior stroke . Time onset wakeup stroke define time patient woke symptom . 7. stem cell transplantation procedure must perform 310 day stroke symptom onset 1 . Ischemic stroke , primary hemorrhagic traumatic lesion brain myocardial infarction within past 30 day prior current stroke . 2 . Mechanical heart valve 3 . Uncontrolled seizure disorder , defined seizure within last 6 month 4 . Developmental delay 5 . Chronic kidney disease 6 . Hepatic disease alter liver function 7 . Pulmonary disease 8 . Cancer within 5 year prior study 9 . Prior immunosuppression , include chemotherapy within last 3 year 10 . Known HIV 11 . Uncorrected coagulopathy severe anemia 12 . Pregnancy 13 . Unable undergo MRI CT scan 14 . Imaging show clinically significant hemorrhage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>83 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ischemic</keyword>
	<keyword>Stroke</keyword>
	<keyword>Stem Cells</keyword>
	<keyword>MSC</keyword>
	<keyword>Allogeneic</keyword>
	<keyword>Bone Marrow</keyword>
</DOC>